Nonapoptotic cell death associated with S-phase arrest of prostate cancer cells via the peroxisome proliferator-activated receptor γ ligand, 15-Deoxy-Δ12,14-prostaglandin J2

Cell Growth and Differentiation

Volumn 11, Issue 1, 2000, Pages 49-61

  Butler, Rachel ^a,b   Mitchell, Susan H ^a   Tindall, Donald J ^a   Young, Charles Y F ^a  

^a MAYO CLINIC   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CIGLITAZONE; DELTA12 PROSTAGLANDIN J2; LIGAND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROSTAGLANDIN;

ADIPOCYTE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE S PHASE; CELL DEATH; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALE; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; PROSTATE CARCINOMA; RECEPTOR DENSITY;

CELL DEATH; CELL MEMBRANE; CELL SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTOCYTOCHEMISTRY; HUMANS; MALE; MEMBRANE POTENTIALS; MICROSCOPY, ELECTRON; MITOCHONDRIA; PROSTAGLANDIN D2; PROSTATIC NEOPLASMS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; S PHASE; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0033950982     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (90)

1. Pienta, K. J., and Esper, P. S. Risk factors for prostate cancer. Ann. Intern. Med., 118: 793-803, 1993.
2. Scardino, P. T. Problem of prostate cancer. J. Urol., 152: 1677-1678, 1994.
3. Walsh, P. C. Prostate cancer kills: strategy to reduce deaths. Urology, 44: 463-466, 1994.
4. Armstrong, B., and Doll, R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int. J. Cancer, 15: 617-631, 1975.
5. Giovannucci, E., Rimm, E. B., Colditz, G. A., Stampfer, M. J., Ascherio, A., Chute, C. C., and Willett, W. C. A prospective study of dietary fat and risk of prostate cancer. J. Natl. Cancer Inst., 85: 1571-1579, 1993.
6. Pienta, K. J., and Esper, P. S. Is dietary fat a risk factor for prostate cancer? J. Natl. Cancer Inst., 85: 1538-1540, 1993.
7. Rose, D. P., and Connolly, J. M. Dietary fat, fatty acids and prostate cancer. Lipids, 27: 798-803, 1992.
8. Pandalai, F. K., Pilat, M. J., Yamazaki, K., Naik, H., and Pienta, K. J. The effects of omega-3 and omega-6 fatty acids on in vitro prostate cancer growth. Anticancer Res., 16: 815-820, 1996.
9. Flanders, W. D. Review. Prostate cancer epidemiology. Prostate, 5: 621-629, 1984.
10. Wang, Y., Corr, J. G., Thaler, H. T., Tao, Y., Fair, W. R., and Heston, W. D. W. Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. J. Natl. Cancer Inst., 87: 1456-1462, 1995.
11. 2: anti-tumor and anti-viral activities and the mechanisms involved. Eicosanoids, 3: 189-199, 1990.
12. Chaudry, A. A., Wahle, K. W. J., McClinton, S., and Moffat, L. E. F. Arachidonic acid metabolism in benign and malignant prostatic tissue in vitro: effects of fatty acids and cyclooxygenase inhibitors. Int. J. Cancer, 57: 176-180, 1994.
13. Robertson, R. P. Prostaglandins and other arachidonic acid metabolites. In: K. L. Becker (ed.), Principles and Practice of Endocrinology and Metabolism, Ed. 2, pp. 1466-1472. Philadelphia: J. B. Lippincott Co., 1995.
14. Harvei, S., Bjerve, K. S., Tretli, E., Robsahm, T. E., and Vatten, L. Prediagnostic level of fatty acids in serum phospholipids: ω-3 and ω-6 fatty acids and the risk of prostate cancer. Int. J. Cancer, 71: 545-551, 1997.
15. Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., and Evans, R. M. The nuclear receptor superfamily: the second decade. Cell, 83: 835-839, 1995.
16. Mangelsdorf, D. J., and Evans, R. M. The RXR heterodimers and orphan receptors. Cell, 83: 841-850, 1995.
17. Fajas, L., Auboeuf, D., Raspe, E., Schoonjans, K., Lefebvre, A. M., Saladin, R., Najib, J., Laville, M., Fruchart, J. C., Deeb, S., Vidal-Puig, A., Flier, J., Briggs, M. R., Staels, B., Vidal, H., and Auwerx, J. The organization, promoter analysis, and expression of the human PPARγ gene. J. Biol. Chem., 272: 18779-18789, 1997.
18. Tontonoz, P., Erding, H., Graves, R. A., Budavri, A. I., and Spiegelman, B. M. mPPARγ2: tissue specific regulator of and adipocyte enhancer. Genes Dev., 8: 1224-1234, 1994.
19. Zhu, Y., Qi, C., Korenberg, J. R., Chen, X. N., Noya, D., Rao, M. S., and Reddy, J. K. Structural organization of mouse peroxisome proliferator-activated receptor γ (mPPARγ) gene: alternative promoter use and different splicing yield two mPPARγ isoforms. Proc. Natl. Acad. Sci. USA, 92: 7921-7925, 1995.
20. Elbrecht, A., Chen, Y., Cullinan, C. A., Hayes, N., Leibowitz, M. D., Moller, D. E., and Berger, J. Molecular cloning, expression and characterization of human peroxisome proliferator-activated receptors γ1 and γ2. Biochem. Biophys. Res. Commun., 224: 431-437, 1996.
21. Vidal-Puig, A., Jimenez-Linan, M., Lowell, B. B., Hamann, A., Hu, E., Spiegelman, B., Flier, J. S., and Moller, D. E. Regulation of PPARγ gene expression by nutrition and obesity in rodents. J. Clin. Investig., 97: 2553-2561, 1996.
22. Gelman, L., Fruchart, J. C., and Auwerx, J. An update on the mechanisms of action of the peroxisome proliferator-activated receptors (PPARS) and their roles in inflammation and cancer. Cell. Mol. Life Sci., 55: 932-943, 1999.
23. Mukherjee, L., Jow, L., Croston, G. E., and Paterniti, J. R. Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPAR-γ2 versus PPAR-γ1 and activation with retinoid X receptor agonists and antagonists. J. Biol. Chem., 272: 8071-8076, 1997.
24. Vidal-Puig, A. J., Considine, R. V., Jimenez-Linan, M., Werman, A., Pories, W. J., Caro, J. F., and Flier, J. S. Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J. Clin. Investig., 99: 2416-2422, 1997.
25. 2 is a ligand for the adipocyte determination factor PPARγ. Cell, 83: 803-812, 1995.
26. 2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell, 83: 813-819, 1995.
27. Yu, K., Bayona, W., Kallen, C. B., Harding, H. P., Ravera, C. P., McMahon, G., Brown, M., and Lazar, M. A. Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J. Biol. Chem., 270: 23975-23983, 1995.
28. Yu, K., Bayona, W., Kallen, C. B., Harding, H. P., Ravera, C. P., McMahon, G., Brown, M., and Lazar, M. A. Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J. Biol. Chem., 270: 23975-23983, 1995.
29. Forman, B. M., Chen, J., and Evans, R. M. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome, proliferator-activated receptors alpha and delta, Proc. Natl. Acad. Sci. USA, 94: 4312-4317, 1997.
30. Jump, D. B., and Clarke, S. D. Regulation of gene expression by dietary fat. Annu. Rev. Nutr., 19: 63-90, 1999.
31. Mueller, E., Sarraf, P., Tontonoz, P., Evans, R. M., Martin, K. J., Zhang, M., Fletcher, C., Singer, S., and Spiegelman, B. M. Terminal differentiation of human breast cancer through PPARγ. Mol. Cell., 1: 465-470, 1998.
32. Tontonoz, P., Singer, S., Forman, B. M., Sarraf, P., Fletcher, J. A., Fletcher, C. D., Brun, R. P., Mueller, E., Altiok, S., Oppenheim, H., Evans, R. M., and Spiegelman, B. M. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor γ and the retinoid X receptor. Proc. Natl. Acad. Sci. USA, 94: 237-241, 1997.
33. Hartwell, L. H., and Weinert, T. A. Checkpoints: controls that ensure the order of cell cycle events. Science (Washington DC), 246: 629-634, 1989.
34. Cao, Z., Umek, R. M., and McKnight, S. L. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev., 5: 1538-1552, 1991.
35. Umek, R. J., Friedman, A. D., and McKnight, S. L. CCAAT-enhancer binding protein: a component of a differentiation switch. Science (Washington DC), 289: 288-292, 1991.
36. Christy, R. J., Faestner, K. H., Geiman, D. E., and McKnight, M. D. CCAAT/enhancer binding protein gene promoter: binding of nuclear factors during differentiation of 3T3-L1 preadipocytes. Proc. Natl. Acad. Sci. USA, 88: 2593-2597, 1991.
37. Wu, Z., Xie, Y., Bucher, N. L. R., and Farmer, S. R. Conditional ectopic expression of C/EBPβ in NIH-3T3 cells induces PPARγ and stimulates adipogenesis. Genes Dev., 9: 2350-2363, 1995.
38. Gimble, J. M., Robinson, C. E., Wu, X., Kelly, K. A., Rodriguez, B. R., Kliewer, S. A., Lehmann, J. M., and Morris, D. C. Peroxisome proliferator-activated receptor-γ activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells. Mol. Pharmacol., 50: 1087-1094, 1996.
39. Hallakou, S., Doare, L., Foufelle, F., Kergoat, M., Guave-Millo, M., Berthault, M. F., Dugail, I., Morin, J., Auwerx, J., and Ferre, P. Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat. Diabetes, 46: 1393-1399, 1997.
40. Arends, M. J., Morris, R. G., and Wyllie, A. H. Apoptosis: the role of the endonuclease. Am. J. Pathol., 136: 593-608, 1990.
41. Kaufmann, S. H., Desnoyers, S., Ottaviano, Y., Davidson, N. E., and Poirier, G. G. Specific cleavage of poly (ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res., 53: 3976-3985, 1993.
42. Costa, A. K., Schieble, T. M., Heffel, D. F., and Trudell, J. R. Toxicity of calcium ionophore A23187 in monolayers of hypoxic hepatocytes. Toxicol. Appl. Pharmacol., 87: 43-47, 1987.
43. Matsubara, K., Kubota, M., Adachi, S., Kuwakado, K., Hirota, H., Wakazono, Y., Akiyama, Y., and Mikawa, H. Different mode of cell death induced by calcium ionophore in human leukemia cell lines: possible role of constitutive endonuclease. Exp. Cell Res., 210: 19-25, 1994.
44. Reers, M., Smith, T. W., and Chen, L. B. J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential. Biochemistry, 30: 4480-4486, 1991.
45. Smiley, S. T., Reers, M., Mottola-Hartson, C., Lin, M., Chen, A., Smith, T. W., Steele, G. D., Jr., and Chen, L. Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Proc. Natl. Acad. Sci. USA, 88: 3671-3675, 1991.
46. Mancini, M., Anderson, B. O., Caldwell, E., Sedghinasab, M., Paty, P. B., and Hockenbery, D. M. Mitochondrial proliferation and paradoxical membrane depolarization during terminal differentiation and apoptosis in a human colon carcinoma cell line. J. Cell Biol., 138: 449-469, 1997.
47. Butler, R., and Young, C. Y-F. Keystone Symposia, February 21-26, 1998. Breast and Prostate Cancer, Abstract No. 204, 1998.
48. Werman, A., Hollenberg, A., Solanes, G., Bjørbæk, C., Vidal-Puig, A. J., and Flier, J. S. Ligand-independent activation domain in the N-terminus of peroxisome proliferator-activated receptor γ (PPARγ). J. Biol. Chem., 272: 20230-20235, 1997.
49. Kubota, T., Koshizuka, K., Williamson, E. A., Asou, H., Said, J. W., Holden, S., Miyoshi, I., and Koeffler, H. P. Ligand for peroxisome proliferator-activated receptor γ (troglitazone) has potent antitumor effects against human prostate cancer both in vitro and in vivo. Cancer Res., 58: 3344-3352, 1998.
50. Carpenter, M., Robinson, R., and Thuy, L. Prostaglandin metabolism by human testis. Lipids, 13: 308-311, 1978.
51. Conte, D., Laguzzi, G., Boniforti, L., Cantafora, A., Di Silverio, F., Latino, C., Lalloui, G., Mesolella, V., and Isidori, A. Prostaglandin content and metabolic activity of the human prostate. In: A. Crastes de Paulet, H. Thalero-Dao, and F. Dray (eds.), Prostaglandins and Reproductive Physiology, Vol. 89. Paris: INSERM, 1980.
52. Benvold, E., Svanborg, K., Bygdeman, M., and Norén, S. On the origin of prostaglandins in human seminal fluid. Int. J. Androl., 8: 37-43, 1995.
53. Tokugawa, Y., Kunishige, I., Kubota, Y., Shimoya, K., Nobunaga, T., Kimura, T., Saji, F., Murata, Y., Eguchi, N., Oda, H., Urade, Y., and Hayaishi, O. Lipocalin-type prostaglandin D synthase in human male reproductive organs and seminal plasma. Biol. Reprod., 58: 600-607, 1998.
54. Altiok, S.,. Xu, M., and Spiegelman, B. M. PPARγ induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A. Genes Dev., 11: 1987-1998, 1997.
55. Elstner, E., Müller, C., Koshijuka, K., Williamson, E. A., Park, D., Asou, H., Shintaku, P., Said, J. W., Heber, D., and Koeffler, H. P. Ligands for peroxisome proliferator-activated receptor γ and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. Proc. Natl. Acad. Sci. USA, 95: 8806-8811, 1998.
56. 2 induce apoptosis in L1210 cells. FEBS Lett., 321: 209-214, 1993.
57. Fukushima, M., Sasaki, H., and Fukushima, S. Prostaglandin J2 and related compounds. Mode of action in G1 arrest and preclinical results. Ann. NY Acad. Sci., 744: 161-165, 1994.
58. Clarke, P. G. H. Developmental cell death: morphological diversity and multiple mechanisms. Anat. Embryol., 181: 195-213, 1990.
59. Hourdry, J. Cytological and cytochemical changes in the intestinal epithelium during anuran metamorphosis. Int. Rev. Cytol. Suppl., 5: 337-385, 1977.
60. Hornung, J. P., Koppel, H., and Clarke, P. G. H. Endocytosis and autophagy in dying neurons: an ultrastructural study in chick embryos. J. Comp. Neurol., 283: 425-437, 1989.
61. Peluso, J. J., England-Charlesworth, C., Bolender, D. L., and Steger, R. W. Ultrastructural alterations associated with the initiation of follicular atresia. Cell Tissue Res., 211: 105-115, 1980.
62. Clarke, P. G. H. Labelling of dying neurons by peroxidase injected intravascularly in chick embryos. Neurosci. Lett., 30: 223-228, 1982.
63. Clarke, P. G. H. Identical populations of phagocytes and dying neurons revealed by intravascularly injected horseradish peroxidase, and by endogenous glutaraldehyde-resistant acid phosphatase, in the brains of chick embryos. Histochem. J., 16: 955-969, 1984.
64. Clarke, P. G. H., and Hornung, J. P. Changes in the nuclei of dying neurons as studied with thymidine autoradiography. J. Comp. Neurol., 283: 438-449, 1989.
65. Tamm, I., Kikuchi, T., and Zychkinsky, A. Acidic and basic fibroblast growth factors are survival factors with distinctive activity in quiescent BALB/c3T3 murine fibroblasts. Proc. Natl. Acad. Sci. USA, 88: 3372-3376, 1991.
66. Mosser, D. D., and Martin, L. H. Induced thermotolerance to apoptosis in human T lymphocyte cell line. J. Cell Physiol., 151: 561-570, 1992.
67. Gordon, S. A., Hoffman, R. A., Simmons, R. L., and Ford, H. R. Induction of heat shock protein 70 protects thymocytes against radiation-induced apoptosis. Arch. Surg., 132: 1277-1282, 1997.
68. Samali, A., and Cotter, T. Heat shock proteins increase resistance to apoptosis. Exp. Cell Res., 223: 163-170, 1996.
69. Mailhos, C., Howard, M. K., and Latchman, D. S. Heat shock protects neuronal cells from programmed cell death by apoptosis. Neuroscience, 55: 621-627, 1993.
70. Green, D. R., and Reed, J. C. Mitochondria and apoptosis. Science (Washington DC), 28 1: 1309-1312, 1998.
71. Susin, S. A., Zamzami, N., and Kroemer, G. Mitochondria as regulators of apoptosis: doubt no more. Biochim. Biophys. Acta, 1366: 151-165, 1998.
72. Fleury, C., Neverova, M., Collins, S., Raimbault, S., Champigny, O., Levi-Meyrueis, C., Bouillard, F., Seldin, M. F., Surwit, R. S., Ricquier, D., and Warden, C. H. Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat. Genet., 15: 269-272, 1997.
73. Yaffe, M. P. The machinery of mitochondrial inheritance and behavior. Science (Washington DC), 283: 1493-1497, 1999.
74. Heggeness, M. H., Simon, M., and Singer, S. J. Association of mitochondria with microtubules in cultured cells. Proc. Natl. Acad. Sci. USA, 75: 3863-3866, 1978.
75. Ball, E. H., and Singer, S. J. Mitochondria are associated with microtubules and not with intermediate filaments in cultured fibroblasts. Proc. Natl. Acad. Sci. USA, 79: 123-126, 1982.
76. Vale, R. D., and Fletterick, R. J. The design plan of kinesin motors. Annu. Rev. Cell Dev. Biol., 13: 745-777, 1997.
77. Tanaka, Y., Kanai, Y., Okada, Y., Nonaka, S., Takeda, S., Harada, A., and Hirokawa, N. Targeted disruption of mouse conventional kinesin heavy chain, kif5B, results in abnormal perinuclear clustering of mitochondria. Cell. 93: 1147-1158, 1998.
78. De Vos, K., Goossens, V., Boone, E., Vercammen, D., Vancompernolle, K., Vandenabeele, P., Haegeman, G., Fiers, W., and Grooten, J. The 55-kDa tumor necrosis factor receptor induces clustering of mitochondria through its membrane-proximal region. J. Biol. Chem., 273: 9673-9680, 1998.
79. Camp, H. S., Whitton, A. L., and Tafuri, S. R. PPARγ activators down-regulate the expression of PPARy in 3T3-L1 adipocytes. FEBS Lett., 186: 186-190, 1999.
80. Cory, A. H., Owen, T. C., Barltrop, J. A., and Cory, J. G. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun., 3: 207-212, 1991.
81. Riss, T. L., and Moravec. R. A. Comparison of MTT, XTT and a novel tetrazolium compound MTS for in vitro proliferation and chemosensitivity assays. Mol. Biol. Cell, 3 (Suppl.): 184a, 1992.
82. Porstmann, T., Temyck, T., and Avrameas, S. Quantitation of 5-bromo-2-deoxyuridine incorporation into DNA: an enzyme immunoassay for the assessment of the lymphoid cell proliferation response. J. Immunol. Methods, 82: 169-179, 1985.
83. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
84. Esquenet, M., Swinnen, J. V., Van Veldhoven, P. P., Denef, C., Heyns, W., and Verhoeven, G. Retinoids stimulate lipid synthesis and accumulation in LNCaP prostatic adenocarcinoma cells. Mol. Cell. Endocrinol., 136: 37-46, 1997.
85. Oberhammer, F. A., Pavelka, M., Sharma, S., Tiefenbacher, R., Purchio, A. F., Busch, W., and Schulte-Hermann, R. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor β-1. Proc. Natl. Acad. Sci. USA, 89: 5402-5412, 1992.
86. Gunji, H., Karbanda, S., and Kufe, D. Induction of internucleosomal DNA fragmentation in human myeloid leukemia cells by 1-β-D-arabinofuranosylcytosine. Cancer Res., 51: 741-743, 1991.
87. Shah, G. M., Kaufmann, S. H., and Poirier, G. G. Detection of poly-(ADP-ribose) polymerase and its apoptosis-specific fragment by a non-isotopic activity-Western blot technique. Anal. Biochem., 232: 251-254, 1995.
88. Zhu, H., Fearnhead, H. O., and Cohen, G. M. An ICE-like protease is a common mediator of apoptosis induced by diverse stimuli in human monocyte THP.1 cells. FEBS Lett., 374: 303-308, 1995.
89. McDowell, E. M., and Trump, B. F. Histologic fixatives suitable for diagnostic light and electron microscopy Arch. Pathol. Lab. Med., 100: 405-414, 1976.
90. Spurr, A. R. A low-viscosity epoxy resin embedding medium for electron microscopy. J. Ultrastruct. Res., 26: 31-43, 1969